GLPBio

Signaling Pathways

Research Area, Signaling Pathways | GlpBio Life Science Products Suppliers

Read More about this category

The antibody-drug conjugate (ADC), a humanized or human monoclonal antibody conjugated with highly cytotoxic small molecules (payloads) through chemical linkers, is a novel therapeutic format and has great potential to make a paradigm shift in cancer chemotherapy. The three components of the ADC together give rise to a powerful oncolytic agent capable of delivering normally intolerable cytotoxins directly to cancer cells, which then internalize and release the cell-destroying drugs. At present, two ADCs, Adcetris and Kadcyla, have received regulatory approval with >40 others in clinical development.

ADCs are administered intravenously in order to prevent the mAb from being destroyed by gastric acids and proteolytic enzymes. The mAb component of the ADC enables it to circulate in the bloodstream until it finds and binds to tumor-specific cell surface antigens present on target cancer cells. Linker chemistry is an important determinant of the safety, specificity, potency and activity of ADCs. Linkers are designed to be stable in the blood stream (to conform to the increased circulation time of mAbs) and labile at the cancer site to allow rapid release of the cytotoxic drug. First generation ADCs made use of early cytotoxins such as the anthracycline, doxorubicin or the anti-metabolite/antifolate agent, methotrexate. Current cytotoxins have far greater potency and can be divided into three main groups: auristatins, maytansines and calicheamicins.

The development of site-specific conjugation methodologies for constructing homogeneous ADCs is an especially promising path to improving ADC design, which will open the way for novel cancer therapeutics.

References:

[1] Tsuchikama K, et al. Protein Cell. 2016 Oct 14. DOI:10.1007/s13238-016-0323-0.

[2] Peters C, et al. Biosci Rep. 2015 Jun 12;35(4). pii: e00225. doi: 10.1042/BSR20150089.

Research Areas

Products Related to Signaling Pathways(40698)

  • GN10527 structure
    GN10527Formononetin
    CAS: 485-72-3
    Purity: >99.50%

    Formononetin est un puissant inhibiteur de FGFR2, sa valeur d'IC50 est 4,3μM. Formononetin inhibe efficacement l'angiogenèse et la croissance tumorale.

  • GN10529 structure
    GN10529Demethoxycurcumin
    CAS: 22608-11-3;24939-17-1
    Purity: >99.00%
  • GN10531 structure
    GN10531Dimethylfraxetin
    CAS: 6035-49-0
    Purity: >99.50%
  • GN10534 structure
    GN10534Asiaticoside
    CAS: 16830-15-2
    Purity: >98.00%

    Asiaticoside est un glycoside triterpénique pentacyclique extrait de Centella asiatica.

  • GN10535 structure
    GN10535Cucurbitacin B
    CAS: 6199-67-3
    Purity: >98.00%

    Cucurbitacin B is a kind of tetracyclic triterpenoid compounds isolated from cucurbitaceae, and exhibits a wide range of biological activities.

  • GN10536 structure
    GN10536Aconine
    CAS: 509-20-6
    Purity: >98.00%
  • GN10538 structure
    GN10538Ginsenoside Rh1
    CAS: 63223-86-9
    Purity: >98.00%
  • GN10539 structure
    GN10539Bergenin
    CAS: 477-90-7
    Purity: >99.50%
  • GN10540 structure
    GN10540Fumalic acid
    CAS: 1135-24-6
    Purity: >99.00%

    A phenol with diverse biological activities.Natural product, extracted from ligusticum chuanxiong.

  • GN10542 structure
    GN10542Scopolamine butylbromide
    CAS: 149-64-4
    Purity: >98.00%
  • GN10543 structure
    GN10543caudatin
    CAS: 38395-02-7
    Purity: >98.00%
  • GN10544 structure
    GN10544Ginsenoside Rg1
    CAS: 22427-39-0
    Purity: >98.00%

    Ginsenoside Rg1, l'un des principaux composants actifs qui sont trouvés dans Panaux giseng, est une classe de produits naturels connus sous le nom de stéroïdes glycosides avec une grande variété d'activités biologiques.

  • GN10545 structure
    GN10545Escin IA
    CAS: 123748-68-5
    Purity: >98.00%
  • GN10547 structure
    GN10547β-Sitosterol
    CAS: 83-46-5
    Purity: >98.00%

    β-Sitosterol est un stérol naturel dérivé des plantes qui possède diverses activités biologiques, comme inhiber le développement du cancer. β-Sitosterol est également communément utilisé pour étudier ses effets sur la santé cardiovasculaire.

  • GN10549 structure
    GN10549Ginsenoside Rd
    CAS: 52705-93-8
    Purity: >98.00%
  • GN10550 structure
    GN10550Neosperidin dihydrochalcone
    CAS: 20702-77-6
    Purity: >98.00%
  • GN10551 structure
    GN10551Licochalcone C
    CAS: 144506-14-9
    Purity: >98.00%
  • GN10552 structure
    GN10552Syringic acid
    CAS: 530-57-4
    Purity: >98.00%

    Syringic acid is a natural phenolic compound with antioxidant, antimicrobial, anti-inflammatory, and antiendotoxic activities.

  • GN10553 structure
    GN10553Glycyrrhizic acid
    CAS: 1405-86-3
    Purity: >98.00%

    Glycyrrhizic acid est la saponine triterpénoïde actif de la réglisse. C'est un antagoniste de la protéine de mobilité élevée 1 (HMGB1), sa valeur de Kd est 4.03μM.

  • GN10554 structure
    GN10554Phytic acid
    CAS: 83-86-3
    Purity: >98.00%

    Phytic acid est un actinutritif naturellement présent dans les graines de légumineuses.

  • GN10555 structure
    GN10555Bilirubin
    CAS: 635-65-4
    Purity: >98.00%

    Bilirubin, un produit de dégradation jaune du catabolisme de l'hème, inhibe la clivage de F485-rVWF73-H, D633-rVWF73-H, et GST-rVWF71-11K par ADAMTS13, ses valeurs d'IC50 sont respectivement 13μM, 70μM, et 17μM.

  • GN10558 structure
    GN10558L-Carnitine inner salt (Standard)
    CAS: 541-15-1
    Purity: >98.00%
  • GN10560 structure
    GN10560α-hederin
    CAS: 27013-91-8
    Purity: >98.00%
  • GN10561 structure
    GN10561astragalin
    CAS: 480-10-4
    Purity: >98.00%

    Astragalin est un composé flavonoïde naturel avec les activités puissantes antioxydantes et anti-inflammatoires et a démontré les applications thérapeutiques potentielles dans les maladies variées, celles qui comprennent le cancer et les maladies cardiovasculaires.